An observational study in Cataract and Pseudophakia, sponsored by Vance Thompson Vision. Completed at 1 site in United States. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2024-05-20.
Sponsored by Vance Thompson Vision · Observational
The objective of this investigator initiated study (IIT-001) is to obtain data on clinical methods which can be used during the examination of patients desiring binocular custom vision with the Light Adjustable Lens (LAL). An analysis of the collected data will be performed to determine whether these clinical assessments can be used by doctors to enhance their patient's clinical outcome.
A population of 25 patients who plan to undergo bilateral cataract surgery with implantation of commercially available Light Adjustable Lens (LAL) and receive binocular custom vision.
Exclusion Criteria:
Subjects that underwent standard of care cataract surgery and LAL IOL placement.
Procedure: LAL IOL lens
Standard of care Cataract surgery with IOL placement
Binocular uncorrected distance, intermediate, and near visual acuity
Time frame: Through Month one post-op
Binocular uncorrected depth of focus
Time frame: Through Month one post-op
Manifest refraction
Time frame: Through Month one post-op
Monocular uncorrected distance visual acuity
Time frame: Through Month one post-op
Monocular best corrected distance visual acuity
Time frame: Through Month one post-op
Visual Satisfaction
Visual satisfaction will be obtained using a visual questionnaire
Time frame: Through Month one post-op
4th order total eye spherical aberration (Z12)
Time frame: Through Month one post-op
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vance Thompson Vision